A possible role for topoisomerase II in cell death and N-phosphonoacetyl-L-aspartate-resistance frequency and its enhancement by 1-β-D-arabinofuranosyl cytosine and 5-fluoro-2'-deoxyuridine

Mutation Research - DNA Repair

Volumn 384, Issue 2, 1997, Pages 89-106

  Goz, Barry ^a   Bastow, Kenneth F ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

1 beta D Arabinofuranosyl cytosine; 5 Fluoro 2' deoxyuridine; Cell death; Etoposide; Gene amplification; N phosphonoacetyl L aspartate; Topoisomerase II

Indexed keywords

CYTARABINE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; FLOXURIDINE; METHOTREXATE; SPARFOSIC ACID; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIVISION; CELL STRAIN BHK; CONTROLLED STUDY; CROSS RESISTANCE; DNA SYNTHESIS; DRUG RESISTANCE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CRICETINAE;

EID: 0030835605     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(97)00016-5     Document Type: Article

References (49)

1. D.V. De Cicco, A.C. Spradling, Localization of a cis-acting element responsible for the developmentally regulated amplification of Drosophila chorion genes, Cell 38 (1984) 45-54.
2. G.R. Stark, Regulation and mechanisms of mammalian gene amplification, Adv. Cancer Res. 61 (1993) 87-113.
3. J.R. Warr, G.F. Atkinson, Genetic aspects of resistance to anticancer drugs, Physiol. Rev. 68 (1988) 1-26.
4. B. Goz, P.L. Carl, T.D. Tlsty, 1-β-D-Arabinofuranosyl cytosine enhancement of resistance to several antineoplastic drugs in mammalian tissue culture cells, Mol. Pharmacol. 36 (1989) 360-365.
5. B. Windle, B.W. Draper, Y. Yin, S. O'Gorman, G.M. Wahl, A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration, Genes Dev. 5 (1991) 160-174.
6. Y.-S. Bae, I. Kawasaki, H. Ikeda, L.F. Liu, Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro, Proc. Natl. Acad Sci. USA 85 (1988) 2076-2080.
7. P. Chartrand, DNA recombination in mammalian cells: potential role of topoisomerases, in: M. Potmesil, K.W. Kohn, L.F. Liu, F.M. Muggia, W.E. Ross, R. Silber (Eds.) DNA Topoisomerases in Cancer, Oxford University Press, New York, 1991, pp. 240-245.
8. K.C. Gale, N. Osheroff, Intrinsic intermolecular DNA ligation activity of eukaryotic topoisomerase II, J. Biol. Chem. 267 (1992) 12090-12097.
9. A.L. Bodley, H.-C. Huang, C. Yu, L.F. Liu, Integration of simian virus 40 into cellular DNA occurs at or near topoisomerase II cleavage hot spots induced by VM-26 (teniposide), Mol. Cell. Biol. 13 (1993) 6190-6200.
10. V.K. Schmidt, B.S. Sorensen, H.V. Sorensen, J. Alsner, O. Westergaard, Intramolecular and intermolecular DNA ligation mediated by topoisomerase II, J. Mol. Biol. 241 (1994) 18-25.
11. P. Bouille', F. Subra, H. Goulaouic, S. Carteau, C. Auclair, Impairment of Moloney murine leukemia virus integration in a cell line underexpressing DNA topoisomerase II, Cancer Res. 55 (1995) 3211-3217.
12. L.E. Dillehay, D. Jacobson-Kram, J.R. Williams, DNA topoisomerases and models of sister-chromatid exchange, Mutation Res. 215 (1989) 15-23.
13. I.D. Hickson, S.L. Davies, S.M. Davies, C.N. Roboson, DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases, Int. J. Radiat. Biol. 58 (1990) 561-568.
14. J.C. Wang, P.R. Caron, R.A. Kim, The role of DNA topoisomerases in recombination and genome stability: a double-edged sword?, Cell 62 (1990) 403-406.
15. P.M. Watt, I.D. Hickson, Structure and function of type II DNA topoisomerases, Biochem. J. 303 (1994) 681-695.
16. C.N. Wiblin, I.A. MacPherson, The transformation of BHK 21 hamster cells by simian virus 40, Int. J. Cancer 10 (1972) 296-309.
17. P.J. Ferguson, M.H. Fisher, J. Stephenson, D.-H. Li, B.-S. Zhou, Y.-C. Cheng, Combined modalities of resistance in etoposide-resistant human KB cell lines, Cancer Res. 48 (1988) 5956-5964.
18. J.A. Endicott, V. Ling, The biochemistry of p-glycoprotein-mediated multidrug resistance, Annu. Rev. Biochem. 58 (1989) 137-171.
19. T.C. Rowe, G.L. Chen, Y.-H. Hsiang, L.F. Liu, DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II, Cancer Res. 46 (1986) 2021-2026.
20. A. Di Leonardo, A. Maddalena, P.C. Avolina, Nalidixic acid resistant V79 cells with reduced DNA topoisomerase II activity and amplification prone phenotype, Mutation Res. 269 (1992) 319-327.
21. C.M. Chresta, R. Hicks, J.A. Hartley, R.L. Souhami, Potentiation of etoposide-induced cytotoxicity and DNA damage in CCRF-CEM cells by pretreatment with non-cytotoxic concentrations of arabinosyl cytosine, Cancer Chemother. Pharmacol. 31 (1992) 139-145.
22. D.J. Fernandes, C.V. Catapano, A.J. Townsend, Topoisomerase-related mechanisms of drug resistance, in: B.A. Teicher (Ed.), Drug Resistance in Oncology, Marcel Dekker, New York, 1993, pp. 479-498.
23. D. Hochhauser, A.L. Harris, The role of topoisomerase lia and β in drug resistance, Cancer Treat. Rev. 19 (1993) 181-194.
24. H. Gunji, S. Kharbanda, D. Kufe, Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosyl cytosine, Cancer Res. 51 (1991) 741-743.
25. M.A. Barry, C.A. Behnke, A. Eastman, Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia, Biochem. Pharmacol. 40 (1990) 2353-2362.
26. R.D. Woessner, T.D.Y. Chung, G.A. Hofmann, M.R. Mattern, C.K. Mirabelli, F.H. Drake, R.K. Johnson, Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170 kD and 180 kD forms of topoisomerase II, Cancer Res. 50 (1990) 2901-2908.
27. R.A. La Biche, B. Goz, Properties of a protease-resistant endonuclease in nuclei from transformed hamster cells, Proc. Am. Assoc. Cancer Res. 33 (1992) 463.
28. E. White, Life, death, and the pursuit of apoptosis, Genes Dev. 10 (1996) 1-15.
29. I. Utz, V. Gekeler, W. Ise, J. Beck, M. Spitaler, H. Grunicke, J. Hofmann, Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines, Anticancer Res. 16 (1996) 289-296.
30. A. Townsend, Y.-C. Cheng, Sequence specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template, Mol. Pharmacol. 32 (1987) 330-339.
31. L.M. Wang, J.C. White, R.L. Capizzi, The effect of ara-C induced inhibition of DNA synthesis on its cellular pharmacology, Cancer Chemother. Pharmacol. 25 (1990) 418-424.
32. R.L. Momparler, A model for the chemotherapy of acute leukemia with 1-β-D-arabinofuranosylcytosine, Cancer Res. 34 (1974) 1775-1787.
33. Q.P. Dou, V.W.Y. Lui, Failure to dephosphorylate retinoblastoma protein in drug-resistant cells, Cancer Res. 55 (1995) 5222-5225.
34. W.C. Earnshaw, A.M. Mackay, Role of nonhistone proteins in the chromosomal events of mitosis, FASEB J. 8 (1994) 947-956.
35. C. Holm, Coming undone: how to untangle a chromosome, Cell 77 (1994) 955-957.
36. C. Holm, T. Stearns, D. Botstein, DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage, Mol. Cell. Biol. 9 (1989) 159-168.
37. K.A. Smith, M.B. Stark, P.A. Gorman, G.R. Stark, Fusions near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells, Proc. Natl. Acad. Sci. USA 89 (1992) 5427-5431.
38. B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, J.D. Watson (1994) Molecular Biology of the Cell, Garland Publishing, New York, London, p. 1286.
39. M.F. Christman, F.S. Dietrich, G.R. Fink, Mitotic recombination in the rDNA of S. cervisiae is suppressed by the combined action of DNA topoisomerase I and II, Cell 55 (1988) 413-425.
40. R.A. Kim, J.C. Wang, A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings, Cell 57 (1989) 975-985.
41. G.M. Wahl, The importance of circular DNA in mammalian gene amplification, Cancer Res. 49 (1989) 1333-1340.
42. A. Di Leonardo, S.P. Linke, Y. Yin, G.M. Wahl, Cell cycle regulation of gene amplification, Cold Spring Harbor Symp. Quant. Biol. 58 (1993) 655-667.
43. S. Cohen, D. Hassin, S. Karby, S. Lavi, Hairpin structures are the primary amplification products: a novel mechanism for generation of inverted repeats during gene amplification, Mol. Cell. Biol. 14 (1994) 782-791.
44. H. Potter, D. Dressler, Genetic recombination: molecular biology, biochemistry, and evolution, in: K.B. Low (Ed.), The Recombination of Genetic Material, Academic Press, San Diego, 1988, pp. 217-282.
45. S.J. Froelich-Ammon, K.C. Gale, N. Osheroff, Site-specific cleavage of a DNA hairpin by topoisomerase II, J. Biol. Chem. 269 (1994) 7719-7725.
46. O. Hyrien, M. Debatisse, G. Buttin, B.R. de Saint Vincent, A hotspot for novel amplification joints in a mosaic of Alu-like repeats and palindromic A + T-rich DNA, EMBO J. 6 (1987) 2401-2408.
47. P.A. Dijkwel, J.L. Hamlin, Matrix attachment regions are positioned near replication initiation sites, genes, and an interamplicon junction in the amplified dihydrofolate reductase domain of Chinese hamster ovary cells, Mol. Cell. Biol. 8 (1988) 5398-5409.
48. T. Kubo, K. Kohno, T. Ohga, K. Taniguchi, K. Kawanaomi, M. Wada, M. Kuwano, DNA Topoisomerase IIα gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells, Cancer Res. 55 (1995) 3860-3864.
49. G. Hagen, S. Muller, M. Beato, G. Suske, Sp1-mediated transcriptional activation is repressed by Sp3, EMBO J. 13 (1994) 3843-3851.